-
1.
公开(公告)号:US5252575A
公开(公告)日:1993-10-12
申请号:US886710
申请日:1992-05-21
IPC分类号: C07D473/18 , C07D473/32 , A61K31/52 , C07D473/26
CPC分类号: C07D473/32 , C07D473/18
摘要: Compounds of formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; andR.sub.2 is C.sub.1-6 alkyl;which are pro-drugs for 9-(3-hydroxyprop-1-oxy)guanine having antiviral activity, a process for their preparation and their use as pharmaceuticals.
摘要翻译: 式(I)化合物及其药学上可接受的盐:其中R 1是氢或羟基; 和R 2是C 1-6烷基; 其为具有抗病毒活性的9-(3-羟基丙-1-氧)鸟嘌呤的前药,其制备方法及其作为药物的用途。
-
公开(公告)号:US5108994A
公开(公告)日:1992-04-28
申请号:US528575
申请日:1990-05-23
IPC分类号: A61K31/675 , A61P31/12 , A61P35/00 , C07F9/165 , C07F9/6506 , C07F9/6512 , C07F9/6561 , C07F9/6574
CPC分类号: C07F9/65616
摘要: Compounds of formula (I), and pharmaceutically acceptable salts thereof: ##STR1## wherein R.sub.1 is hydroxy or amino;R.sub.2 is hydrogen or amino;R.sub.3 is hydrogen, hydroxymethyl or acyloxymethyl;R.sub.4 is a group of formula: ##STR2## wherein R.sub.5 and R.sub.6 are independently selected from hydrogen, C.sub.1-6 alkyl and optionally substituted phenyl; orR.sub.3 and R.sub.4 together are: ##STR3## wherein R.sub.6 is as defined above;having antiviral activity, processes for their preparation and their pharmaceutical use.
-